Treatment options when breast cancer becomes unresponsive to chemotherapy
UC expert speaks with Everyday Health
The University of Cincinnati's Mahmoud Charif was featured in an Everyday Health article discussing treatment options when metastatic triple-negative breast cancer (mTNBC) becomes unresponsive to chemotherapy.
Even though chemotherapy is the standard treatment for mTNBC, it’s not uncommon for these drugs to stop working eventually.
Charif, MD, a University of Cincinnati Cancer Center member, associate professor in the UC College of Medicine and a UC Health physician, said breast cancer cells can become resistant to chemotherapy over time, making the treatment less effective. This is especially the case for mTNBC, which is typically a more aggressive form of cancer.
Treatment options when mTNBC becomes unresponsive to chemotherapy include immunotherapy, clinical trials and a class of drugs called antibody-drug conjugates (ADCs). Charif explained ADCs combine an antibody therapy and chemotherapy to work together to kill cancer cells.
Read the Everyday Health article.
Featured photo of 3D breast cancer cell courtesy of the National Cancer Institute.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.